A critical advance in cancer study is arising with the use of VHH fragments to restore mutated p53. This vital malignant inhibitor protein is frequently inactivated in several forms of malignancies, causing https://bookmarkextent.com/story24145594/mini-antibodies-revive-tumor-suppressor-p53-the-new-pathway-for-cancer-therapy